{"id":"NCT00891462","sponsor":"AstraZeneca","briefTitle":"Efficacy and Safety of Aclidinium Bromide for Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-33)","officialTitle":"Efficacy and Safety of Aclidinium Bromide at Two Dose Levels (200 μg Twice Daily, 400 μg Twice Daily) vs. Placebo When Administered to Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-04","primaryCompletion":"2009-11","completion":"2009-11","firstPosted":"2009-05-01","resultsPosted":"2012-09-13","lastUpdate":"2017-01-06"},"enrollment":561,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Obstructive Pulmonary Disease"],"interventions":[{"type":"DRUG","name":"Aclidinium bromide","otherNames":[]},{"type":"DRUG","name":"Aclidinium bromide","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"EXPERIMENTAL"},{"label":"3","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to assess the efficacy (effectiveness) and safety of aclidinium bromide doses as compared to placebo in the treatment of moderate to severe chronic obstructive pulmonary disease. The study will be 16 weeks in duration; 2-week run-in period, 12-week double-blind treatment, and 2-week follow-up phone visit.","primaryOutcome":{"measure":"Change From Baseline in Morning Pre-dose Forced Expiratory Volume in 1 Second (FEV1)","timeFrame":"Change from Baseline to 12 weeks","effectByArm":[{"arm":"Placebo","deltaMin":-0.025,"sd":0.015},{"arm":"Aclidinium Bromide, 200µg","deltaMin":0.062,"sd":0.015},{"arm":"Aclidinium Bromide, 400µg","deltaMin":0.099,"sd":0.015}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"},{"comp":"OG000 vs OG002","p":"<0.0001"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":8},"locations":{"siteCount":112,"countries":["United States","Canada"]},"refs":{"pmids":["28074135","22320148"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":186},"commonTop":["Chronic obstructive pulmonary disease"]}}